Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06454617

Calibr-Ì: Comparative Evaluation of Phantomless Calibration Methods to Quantify Bone Mineral Density for Opportunistic Analysis of CT Scans

Comparative Evaluation of Phantomless Calibration Methods to Quantify Bone Mineral Density for Opportunistic Analysis of CT Scans

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Istituto Ortopedico Rizzoli · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Osteoporosis is a systemic disease characterized by a reduction in bone mineral density (BMD) and qualitative alteration of the skeleton, resulting in increased bone fragility and fracture risk. The epidemiological impact of osteoporosis is extremely high. Proper diagnosis and clinical management of osteoporosis are critical to reducing the incidence of fragility fractures and preventing their complications. The diagnosis is generally confirmed by instrumental analysis of bone mineral density. The standard method is X-ray bone densitometry (DXA), which allows diagnosis based on criteria defined by the World Health Organization (WHO) by virtue of the T-score. DXA is a relatively quick and inexpensive examination with low exposure to ionizing radiation. However, this method has limitations in detecting fracture risk, and in addition, not all patients are properly referred for DXA services, which, among other things, require specific criteria to be reimbursed by the National Health System. Currently, computed tomography (CT) scanning is the most widely used three-dimensional diagnostic modality in clinical practice, and the number of investigations performed in high-income countries is continuously growing. Quantitative assessment of bone mineral density by CT is possible by proper calibration of the machine for the purpose of converting the CT numbers (or Hounsfield units) measured by the scanner into BMD units.

Conditions

Interventions

TypeNameDescription
OTHERPhantomThe patients will be simultaneously scanned with a QCT phantom

Timeline

Start date
2024-06-06
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2024-06-12
Last updated
2025-06-10

Locations

2 sites across 2 countries: Italy, New Zealand

Source: ClinicalTrials.gov record NCT06454617. Inclusion in this directory is not an endorsement.